Login

Jesse Ledger, Chief Executive Officer, Nuvo Pharmaceuticals Inc. 00:00:00

Share On Facebook Share On Twitter

Nuvo Pharmaceuticals Inc.

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
Brickworks Ltd MD Discusses Full Year Results, Property Trust, and Dividend Policy with Tom Piotrowski | Lindsay Partridge - CEO of brickworks ltd
00:10:00
How 1-800-Flowers.com is Revolutionizing Mother's Day Shopping with AI-Powered 'GWYN' | Christopher McCann, CEO , 1-800-Flowers.com Inc.
00:10:00
Staying True: The Journey of a Quant Investor | Cliff Asness, Chief Investment Officer , AQR Capital.
00:10:00
Private Equity Insights: Exploring Base Metals and Emerging Markets
00:10:00
Insights from a Discussion on Insurance Investments | Woody Bradford, CEO ,Conning.
00:10:00
Achieving Financial Success with Michael McCoy | Michael McCoy, New Wealth Advisors Club
00:10:00
Newfoundland and Labrador Invest in Critical Mineral Exploration | Andrew Furey - premier of Newfoundland and Labrador
00:10:00
David Solomon on Goldman Sachs' Strategic Moves Amid Crisis and Future Outlook | David Solomon, CEO, Goldman Sachs.
00:10:00
Metals Creek Resources: Gold Exploration in Uncertain Times
00:10:00
Overview of Element 29 Resources and Its Copper Projects in Peru
00:10:00
Prof. Daniel Kahneman: The Art and Science of Decision Making – A Deep Dive into Human Choices in Business, Science, and Life with Nobel Laureate and Behavioral Economist
00:10:00
Integrating Managerial Insight with Optimal Algorithms|Blair Flicker,Managing Director and General Counsel,Insight Partners

© 2026 Nehu